Auxly Cannabis Group Inc. (TSX:XLY)
0.1750
0.00 (0.00%)
Jun 30, 2026, 3:59 PM EST
Auxly Cannabis Group Revenue
Auxly Cannabis Group had revenue of 39.75M CAD in the quarter ending March 31, 2026, with 21.68% growth. This brings the company's revenue in the last twelve months to 158.57M, up 22.20% year-over-year. In the year 2025, Auxly Cannabis Group had annual revenue of 151.48M with 23.83% growth.
Revenue (ttm)
158.57M
Revenue Growth
+22.20%
P/S Ratio
1.58
Revenue / Employee
355.53K
Employees
446
Market Cap
250.87M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 151.48M | 29.15M | 23.83% |
| Dec 31, 2024 | 122.33M | 21.25M | 21.02% |
| Dec 31, 2023 | 101.08M | 6.61M | 6.99% |
| Dec 31, 2022 | 94.47M | 10.64M | 12.70% |
| Dec 31, 2021 | 83.83M | 37.11M | 79.43% |
| Dec 31, 2020 | 46.72M | 38.37M | 459.38% |
| Dec 31, 2019 | 8.35M | 7.61M | 1,018.07% |
| Dec 31, 2018 | 747.00K | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | 257.21K | -17.84K | -6.49% |
| Dec 31, 2014 | 275.05K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cresco Labs | 895.33M |
| Ascend Wellness Holdings | 683.30M |
| TerrAscend | 365.43M |
| Aurora Cannabis | 320.59M |
| Organigram Global | 274.19M |
| Medexus Pharmaceuticals | 138.65M |
| Cannara Biotech | 113.01M |
| Cipher Pharmaceuticals | 71.10M |
Auxly Cannabis Group News
- 27 days ago - Red White & Bloom Brands' Subsidiary, Emblem Cannabis Corporation, Assumes Debtor-In-Possession Financing for Ayurcann Following Assignment From Auxly Cannabis Group - GlobeNewsWire
- 4 weeks ago - Auxly Cannabis Group Transcript: Lytham Partners Spring 2026 Investor Conference - Transcripts
- 6 weeks ago - Auxly Cannabis Group Earnings Call Transcript: Q1 2026 - Transcripts
- 6 weeks ago - Auxly Cannabis Group Registration statement: Q1 2026 - Filings
- 6 weeks ago - Auxly Cannabis Group Registration statement: Q1 2026 - Filings
- 6 weeks ago - Auxly Cannabis Group Earnings release: Q1 2026 - Filings
- 6 weeks ago - Auxly Cannabis Group Shareholder letter: Q1 2026 - Filings
- 7 weeks ago - Auxly Cannabis Group Slides: Investor presentation - Filings